Bridgeway Capital Management »

Actuate Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $190k 31k 6.12